Status:
COMPLETED
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
Lead Sponsor:
University of Cincinnati
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to see if people can produce ketones in their blood with the modified Atkins diet. Modified Atkins diet is a diet that produces ketones in your blood by restricti...
Eligibility Criteria
Inclusion
- Histologically confirmed primary malignant glioma, Grade III or IV
- No uncontrolled infection or other active malignancy or chronic systemic immune therapy.
- ECOG performance status \< 3.
- Life expectancy \> three months.
- Adequate labs
Exclusion
- Diagnosis of genetic disorder of fat metabolism.
- Type 2 diabetes diagnosed with a hemoglobin A1C \> 6.4
- Allergic to dairy or lactose intolerance
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03278249
Start Date
October 12 2017
End Date
January 1 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Health
Cincinnati, Ohio, United States, 45219